Skip to content
Use caution Drug recall · FDA · Published August 28, 2015

Eagle Pharmacy Recalls Lipo B Sterile Injection Due to Subpotency

Eagle Pharmacy recalls 104 vials of Lipo B Sterile Injection due to subpotent drug levels. Check lot #07072015LIPO if you purchased in TN or AL.

🇺🇸 FDA recall #D-1832-2015DrugEagle Pharmacy ›
Take action

Contact the company

Recalling firmEagle Pharmacy, Inc.2200 Riverchase Ctr Ste 675 · Hoover, AL 35244-2918
✎ GovInfoNow plain-language explainer

What happened, in plain English

Eagle Pharmacy, Inc. is recalling a specific lot of Lipo B Sterile Injection because the drug may be subpotent due to trace amounts of methylcobalamin. The recall affects 104 multidose vials distributed in Tennessee and Alabama. No remedy or return instructions are currently listed in the record. Read more at govinfonow.com/recall/43782-eagle-pharmacy-inc-recalls-lipo-b-sterile-injection-10-ml.

Source Summary by GovInfoNow · govinfonow.com/recall/43782-eagle-pharmacy-inc-recalls-lipo-b-sterile-injection-10-ml · Updated October 12, 2026 · FDA enforcement record: FDA #D-1832-2015

Cite this page

“Eagle Pharmacy Recalls Lipo B Sterile Injection Due to Subpotency.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43782-eagle-pharmacy-inc-recalls-lipo-b-sterile-injection-10-ml. Based on FDA recall #D-1832-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1832-2015%22&limit=1).

Why it’s dangerous

The drug is classified as subpotent because it contains trace amounts of methylcobalamin, which may alter its intended potency. This could potentially reduce the effectiveness of the treatment for patients relying on this specific formulation.

Who’s affected

Patients who received compounded Lipo B Sterile Injection from Eagle Pharmacy in Birmingham, AL, specifically those in Tennessee and Alabama. The risk applies to users of the specific lot distributed before the recall date.

How to tell if you have this one

Look for LIPO B STERILE INJECTION 10 mL vials compounded by Eagle Pharmacy, Inc. in Birmingham, AL. Identify the specific lot number #07072015LIPO and an expiration date of 12/15. These items were distributed in Tennessee and Alabama.

  • Brand
    Eagle Pharmacy
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Lot Number

    Verify if your vial matches lot #07072015LIPO with an expiration date of 12/15.

  2. Contact the Manufacturer

    Reach out to Eagle Pharmacy, Inc. in Birmingham, AL for further instructions since no remedy is listed in the record.

Where it went and when

Where it was distributed

Distributed in Alabama and Tennessee.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: yesTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: yesALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “TN, AL” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Alabama, Tennessee.

Recall timeline

FDA terminated this recall 3 months after the firm started it.

1. Firm started the recall: Aug 28, 201512. FDA classified it Class II: Sep 29, 201523. Published in FDA’s Enforcement Report: Oct 7, 201534. FDA terminated the recall: Nov 30, 201542015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1832-2015 (August 28, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1832-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA